# A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

> clinical trial · VERIFIED · 2026-06-12

Status: RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Down Syndrome

- Company: National Cancer Institute (NCI)
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT04546399

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.